Esomeprazole 20mg: Clinical Trials

10 trials of Esomeprazole 20mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown, 1 not yet recruiting, 1 recruiting. 4 Phase 4, 3 Phase 1, 2 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Recruiting 1, Unknown 1
Phase 13Unknown 2, Completed 1
Not applicable2Completed 1, Not yet recruiting 1
Phase 21Completed 1

Follow Esomeprazole 20mg: new trials by email Literature Review of Esomeprazole 20mg trials Research Report on Esomeprazole 20mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mirgeal® Gel as Add-on Therapy to Esomeprazole in Adults With Non-Erosive Gastroesophageal Reflux Disease
Esomeprazole 20mg, Mirgeal® Gel (manufacturer: PharmExtracta S.p.A.) - Non-Erosive Gastroesophageal Reflux Disease (NERD)
Not applicableNot yet recruitingLiaquat University of Medical & Health Sciences1402026-09-072026-08-27
Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects
Clopidogrel 75 mg, Tegoprazan 25 mg, Esomeprazole 20mg - Healthy
Phase 1UnknownHK inno.N Corporation482023-12-052023-12-11
Metformin and Esomeprazole For Preterm Pre-eclampsia
Esomeprazole 20mg - Preeclampsia Severe, Preeclampsia Second Trimester
Phase 1UnknownChristiana Care Health Services382023-03-012023-02-10
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses
Amoxicillin, Tetracycline tid, Tetracycline qid - Helicobacter Pylori Infection
Phase 4CompletedShandong University4062022-07-012024-03-27
Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial
Placebo, Esomeprazole 20mg - Liver Cirrhosis
Phase 4RecruitingUniversitätsklinikum Hamburg-Eppendorf4762021-04-222025-04-24
A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole
AD-206 20mg, Esomeprazole 20mg, AD-206 40mg - Gastritis
Phase 1CompletedAddpharma Inc.882019-06-052021-01-13
A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis
Omeprazole 20mg, Esomeprazole 20mg, Rabeprazole Sodium 20mg - Helicobacter Pylori Infection
Phase 4UnknownChangi General Hospital2522019-04-162020-10-08
The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty
Oxycodone, Tramadol, Tylenol - Osteo Arthritis Knee
Not applicableCompletedRothman Institute Orthopaedics2162017-12-212019-07-01
Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)
YH1885L(Revaprazan), Esomeprazole 20mg, placebo - Non-erosive Reflux Disease
Phase 2CompletedYuhan Corporation1492013-01-012014-07-10
BRAVO Study for Functional Dyspepsia
Esomeprazole 20mg, Placebo - Dyspepsia, Gastroesophageal Reflux
Phase 4CompletedChinese University of Hong Kong1302011-08-242019-01-31

Conditions studied

Dyspepsia (1)  ·  Fibrosis (1)  ·  Gastritis (1)  ·  Gastroesophageal Reflux (1)  ·  Liver Cirrhosis (1)  ·  Non-Erosive Reflux Disease (1)

Sponsors

Addpharma Inc. (1)  ·  Changi General Hospital (1)  ·  Chinese University of Hong Kong (1)  ·  Christiana Care Health Services (1)  ·  HK inno.N Corporation (1)  ·  Liaquat University of Medical & Health Sciences (1)  ·  Rothman Institute Orthopaedics (1)  ·  Shandong University (1)  ·  Universitätsklinikum Hamburg-Eppendorf (1)  ·  Yuhan Corporation (1)

Countries

South Korea (3)  ·  United States (2)  ·  China (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Singapore (1)

Top investigators

Ansgar W Lohse, MD (1)  ·  Daphne Shih Wen Ang, MD (1)  ·  In-Jin Jang, M.D.,Ph.D (1)  ·  Johannes Kluwe, MD (1)  ·  Justin CY Wu, MBChB(CUHK) (1)  ·  Matthew Hoffman, MD, MPH (1)  ·  Seung Hwan Lee (1)  ·  Xiuli Zuo, MD,PhD (1)

Results publications

PMID 33036845, PMID 39097924

NIH funding

2019 (1), 2023 (1)